By Adam Bonislawski
Vermillion said this week that it sold more than 3,000 of its OVA1 ovarian cancer tests in the first quarter and generated $431,000 in total revenue, compared to revenue of $73,000 in Q1 2010.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.
A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.
A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.
The BabySeq project to study the risks and benefits of sequencing newborns is underway.